Introduction
Cognitive impairment of patients with cardiac failure [1] , and improvements in cognitive function following cardiac transplantation have been reported [2, 3] . Hence, a link between impaired heart function and cerebral perfusion deficits can be postulated. Cerebral perfusion deficits are potentially further aggravated by the use of vasodilating agents. We thus reasoned that some of these patients potentially have impaired cerebrovascular reactivity.
Carbon dioxide (CO 2 ) is a potent cerebral vasomotor agent; increases in arterial CO 2 partial pressure normally result in an almost immediate increase of cerebral blood flow. Assessment of this reaction, i.e. of cerebral vasoreactivity, can easily be performed with transcranial Doppler, using a hypercapnic gas mixture as a provoking factor. Transcranial Doppler provides instantaneous measurement of blood flow velocity of the basal cerebral arteries. Changes in arterial CO 2 partial pressure have been shown to influence the diameter of the brain arterioles and pre-capillary sphincters [4] , rather than that of the basal arteries [5, 6] . Thus, alterations in flow velocity values evaluated with transcranial Doppler provide semiquantitative information on changes of cerebral perfusion. Several studies have demonstrated the clinical relevance of cerebral vasoreactivity, as assessed with transcranial Doppler, in identifying stroke-prone patients [7] [8] [9] . We performed this study to evaluate potential changes in the cerebrovascular reactivity of patients with cardiac failure and their consequent dependence on cardiac functional variables.
Methods

Study population
A total of 50 patients with cardiac failure, 38 men and 12 women, aged 59 11 years (mean SD), 20 controls, 13 men and seven women, aged 57 9 years (mean SD) and 20 healthy volunteers, 11 men and nine women, aged 29 11 years (mean SD) were examined in this study after informed consent.
Underlying cardiac disease was dilative idiopathic cardiomyopathy in 13 cases, ischaemic disease in 32 cases and other diseases in five cases (alcoholic cardiomyopathy and infective endocarditis). Cardiac rhythm was sinus in 37, and atrial fibrillation in 10 cases, while three patients carried a pacemaker. New York Heart Association (NYHA) criteria were used to evaluate the degree of heart failure. Transthoracic echocardiography for evaluation of left ventricular ejection fraction and evaluation of the carotid arteries by means of continuous wave Doppler were performed in all patients. Left ventricular end-diastolic pressure was evaluated during cardiac catheterization. Patients with additional carotid disease (>50% stenosis), or patients with a history of stroke, transient ischaemic attack or other pre-existing neurological disease were not included in this study. Medication of the examined patients is listed in Table 1 .
Age-matched controls were recruited from the neurology wards (sex and age distribution are listed in Table  1 ). Underlying disease in these cases was herniated lumbar disc (n=2), epilepsy (n=2), tension headache (n=1), myositis (n=3), multiple sclerosis (n=2), paroxysmal positional vertigo (n=1) or polyneuropathy (n=9). None of these patients was receiving any drugs known to affect vasal tone. Extra-and intracranial brain supplying arteries were examined with continuous wave and transcranial Doppler ultrasound. No echocardiographic studies were performed in these patients, but there was no suggestion of cardiac disease on medical history or electrocardiography. Healthy volunteers were medical students or members of staff without any history of previous disease. No diagnostic studies were performed in these cases.
Evaluation of CO 2 -reactivity
Bilateral transcranial Doppler monitoring was performed over the middle cerebral arteries(s) using 2 MHz probes from a pulsed Doppler machine (Multi-Dop X-4, DWL), in the presence of an experienced examiner. The subjects were initially monitored at rest, while breathing room air. Five minutes later, they were instructed to breathe into a tube, ending in two plastic bags, each of which had a capacity of 5 l. A nose clip was used to prevent nasal breathing. The subjects were instructed to breathe normally and avoid hyper-or hypoventilating. Duration of hypercapnia was subject to tolerability. Patients simply removed the tube from their mouths when breathing became uncomfortable, and continued breathing room air. End-tidal CO 2 concentration was continuously measured using a Capnometer (Normocap oxy, Engströ m, Finland). These data were harvested on-line by the ultrasound machine. After the examination, end-tidal CO 2 values before hypercapnia induction (after a stabilization period of at least 3 min), as well as peak CO 2 values and corresponding mean blood flow velocities (V m ) in the right and left middle cerebral arteries were noted (Fig. 1) . Cerebrovascular reactivity (CR) was calculated according to the formula [10] :
whereby (h) stands for hypercapnia and (n) for normocapnia.
Statistical analysis
Normally and non-normally distributed data were expressed as mean standard error and as median, [95% confidence intervals] respectively. Unpaired t-test was used to compare normally distributed data, the 
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Results
The degree of cardiac failure and clinical variables of the 50 patients with cardiac failure and the 20 controls are listed in Table 1 . No significant differences in age or sex distribution were evident among the four groups. Left ventricular ejection fraction was significantly lower in patients with NYHA IV as compared to those with NYHA III and NYHA II (P<0·001 and P<0·0002 respectively, Mann-Whitney test), while no significant differences were evident between NYHA II and NYHA III patients (Table 1) . No significant differences in left ventricular end-diastolic pressure were evident among the three groups. Equally, no significant differences in drug regimes were noted. All patients treated with beta-blockers were receiving metoprolole, with the exception of a single case receiving bisoprololfumarate. Healthy controls were significantly younger compared to the examined patients (all P<0·001, two-sample t-test). No significant differences in CO 2 reactivity were noted when comparing the right and left middle cerebral arteries or the results of the two separate examinations (right middle cerebral arteries 7·3 1·6 and 7·4 2 mmHg 1 and left middle cerebral arteries 7·4 1·9 and 7·4 2·3 mmHg 1 , all differences P>0·9, twosample t-test). The highest discrepancy observed was 11·7% between subsequent measurements and 13·7% between right and left middle cerebral arteries. Linear regression analysis disclosed a highly significant correlation between the results of the two subsequent measurements (r=0·78, P<0·0001, Fig. 2) .
No patient was hypercapnic at baseline, or demonstrated pathological breathing patterns, such as periodic breathing, known to affect oxygen saturation in chronic heart failure patients [11] . No significant differences in baseline CO 2 or middle cerebral arteries mean velocity values were observed among the NYHA subgroups and the control subjects (Table 1) . Additionally, no significant changes in heart rate or blood pressure were noted throughout transcranial Doppler monitoring. No statistically significant differences were evident between cerebrovascular reactivity results of the right and left middle cerebral arteries. Therefore, cerebrovascular reactivity values in each patient were expressed as an average of the values derived from the right and left middle cerebral arteries. Cerebrovascular reactivity was significantly higher in controls as compared to all patient groups, and in NYHA II and NYHA III as compared to NYHA IV patients; no significant differences were evident between NYHA II and NYHA III patients (Fig. 3) .
Multivariable analysis revealed left ventricular ejection fraction as a significant predictor of cerebrovascular reactivity, independent of patients' age and sex, left ventricular end-diastolic pressure and medication (Table  2) . Linear regression analysis demonstrated a significant relationship between left ventricular ejection fraction and cerebrovascular reactivity; the derived equation was cerebrovascular reactivity=3·2+0·05 left ventricular ejection fraction (%), (R 2 =0·21, S y.x =1·714 and P<0·001, Fig. 4 ). The same was true for the relationship between NYHA and cerebrovascular reactivity (equation: cerebrovascular reactivity=9·1 -1·5 NYHA, R 2 =0·31, S y.x =1·61, P<0·0001). Correlation between cerebrovascular reactivity and patients' age and left ventricular end-diastolic pressure failed to reach statistical significance (P=0·1 and 0·4, respectively). 
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No significant differences in cerebrovascular reactivity between patients receiving beta-blockers and the remaining cases were observed in any NYHA group ( 
Discussion
To the best of our knowledge, this is the first study examining cerebrovascular reactivity in patients with cardiac failure. The main findings of this study were: (i) impaired cerebrovascular reactivity in patients with chronic heart failure, and (ii) a relationship between the decline in cardiac function and the decrease in cerebrovascular reactivity.
Our results were not biased by age-related variables, since no significant difference was present among the NYHA classes and the group of control patients ( Table  1 ). An obvious limitation of our study was the fact that patients with cardiac failure were receiving a number of vasoactive drugs, and in particular nitrates, known to induce dilation of the main trunk of the middle cerebral artery [12] . However, subgroup analysis between patients receiving certain agents and those who were not, as well as multivariable analysis, disclosed no significant drug effects on cerebrovascular reactivity. Finally, the method showed good reproducibility, as demonstrated by the lack of discrepancies between the two sides and between repeated measurements of healthy volunteers.
Inadequate cerebral perfusion could only be hypothesized in chronic heart failure patients on the basis of previous findings demonstrating cognitive impairment in patients with severe decline in cardiac function [1] , and a significant recovery of cognitive deficit after cardiac transplantation [2, 3] . Nonetheless, the reduction in cardiac output in patients with adequate cerebrovascular reactivity could be compensated for by lowering cerebrovascular resistance through dilatation of the brain arterioles. Obviously, this would limit the potential for further dilatation, thus resulting in altered cerebrovascular reserve capacity, as was observed in our study, even in patients with partially compensated cardiac failure (NYHA II). Patients whose brain resistance vessels demonstrate a partially exhausted reactive dilatory capacity are potentially unable to compensate for the effects of systemic arterial blood pressure lowering induced by diuretic and vasodilating medication on cerebral perfusion.
Determining the caused for the decline in cerebrovascular reactivity in chronic heart failure patients was not the aim of our study. Nonetheless, the linear regression analysis that we performed on left ventricular ejection fraction and cerebrovascular reactivity data (Fig. 3 ) underlines a significant relationship between the decline in cardiac function and the reduction in cerebrovascular reactivity. We excluded the presence of hypercapnia at baseline in our patients, since we obviously considered hypercapnia as the major potential determinant of false-positive results in decreased cerebrovascular reactivity. We thus consider the highly Several animal studies demonstrated deterioration of cognitive function as a result of chronic cerebral hypoperfusion: the animals showed impairment of learning [13, 14] and memory performance [13, [15] [16] [17] , which corresponded to late loss of hippocompal cells [13] [14] [15] [16] [17] and gliosis of the white matter [14] . Interestingly, these changes were observed following chronic rather than acute hypoperfusion (190 days in one study [15] , 4 months [13] and 27 weeks [17] in two others). Similar changes can be postulated in patients with cardiac failure, although no pathoanatomical studies exist in these cases.
In conclusion, our data are the first evidence that a decline in left ventricular ejection fraction is related to partial recruitment of cerebrovascular reactive dilatory capacity in patients with chronic heart failure. The demonstrated decline in cerebrovascular reserve capacity could be responsible for cognitive brain dysfunction in patients with chronic heart failure.
